SLU-PP-322
ERR agonist researched for exercise mimetic effects and mitochondrial biogenesis.
Testing & quality
Every batch is supplier-tested for identity and purity and randomly verified by independent third-party HPLC and mass spectrometry.
About SLU-PP-322
SLU-PP-322 is not a peptide — it's a small molecule that switches on ERR receptors, the genes that control how much energy muscle cells burn. Labs call it an exercise mimic because treated muscle cells build more mitochondria and burn more fat without any exercise involved.
It is used to study endurance-type changes, fat burning, and heat production in cells. Supplied as a research-grade powder at 99%+ purity for laboratory use only.
What animal studies have reported
These are outcomes published in peer-reviewed animal (preclinical) research on SLU-PP-322. They describe results seen in laboratory animals only.
- Increased fat burning and reduced weight gain in obese mice
- More mitochondria in muscle tissue
- Improved running endurance without training
Animal findings do not predict results in humans. Nothing here is a claim about human use — this product is sold for laboratory research only.
Compound classification
Small-molecule pan-Estrogen-Related Receptor (ERRα/β/γ) agonist.
Mechanism studied in the literature
Activates ERR transcription factors that govern mitochondrial biogenesis, fatty-acid oxidation, and oxidative phosphorylation gene programs. Studied in vitro and in rodent models as a putative exercise mimetic.
Research areas
- Mitochondrial biogenesis pathways
- Fatty-acid oxidation and skeletal muscle metabolism (preclinical)
- Exercise mimetic compound screening
- ERR receptor pharmacology
Storage
Lyophilized: -20°C, protected from light. Once in solution: 2-8°C, short-term storage only.
Reconstitution (laboratory)
Soluble in DMSO for in-vitro work. For sterile aqueous reconstitution use bacteriostatic water; concentration depends on the research protocol.
Related research peptides
NSL-3 RT
Triple agonist (GLP-1 / GIP / glucagon) studied for body composition and metabolic regulation research.
NSL-2 TRZ
Dual GIP / GLP-1 receptor agonist studied for glycemic control and metabolic pathway research.
MOTS-c
Mitochondrial-derived peptide studied for insulin sensitivity, energy expenditure, and metabolic homeostasis.
AOD-9604
HGH fragment 176-191 studied for lipolytic and metabolic pathway research.